Alertgy

Alertgy is a medical technology firm focused on the development of non-invasive continuous glucose monitoring (CGM) solutions. The company was founded in 2016 by Marc Rippen, who serves as the President. Rippen's background as a retired U.S. Air Force Lieutenant Colonel and his experience as an engineer and program manager in advanced technology development for defense and aerospace have shaped the company's approach to creating a novel dielectric spectroscopy-based sensor. This technological foundation aims to provide a pain-free alternative for individuals with diabetes to manage their blood glucose levels.

The core of Alertgy's offering is the Alertgy CGM system, which utilizes a wearable wristband sensor, the DeepGluco. This device measures blood glucose levels from the tissue and blood vessels around the wrist without requiring skin penetration. The technology works by sending low-power radio waves through the skin to measure changes in the body's dielectric properties, which correlate to glucose concentrations. The data is then transmitted via Bluetooth to a smartphone application, providing real-time glucose readings, alerts, and historical data tracking for the user and designated caregivers or healthcare providers. This approach eliminates the need for painful finger pricks or implanted sensors, a significant differentiator in the diabetes care market.

The company targets the expansive global diabetes management market, which includes individuals with Type 1, Type 2, and pre-diabetes. Alertgy's business model appears to be centered on the sale of its DeepGluco device, positioning it as a direct competitor to established players in the CGM space like Dexcom and Abbott. By offering a non-invasive and convenient solution, the company aims to improve the quality of life and adherence to glucose monitoring for millions of patients. The company has engaged in multiple equity crowdfunding campaigns to finance its research, development, and path to regulatory approval from bodies like the FDA.

Keywords: non-invasive glucose monitoring, CGM, medical device, diabetes care, wearable technology, dielectric spectroscopy, digital health, blood glucose sensor, medtech, mobile health